Related Experiment Video

Updated: Jan 9, 2026

Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
14:01

Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry

Published on: September 13, 2022

5.6K

Adverse Events in Patients Aged >85 vs <85 Years With Advanced Basal Cell Carcinoma Treated With Sonidegib

A Jiménez-Sánchez1, Ó Muñoz Moreno-Arrones2, S Béa-Ardebol2

  • 1Departamento de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain; Departamento de Dermatología, Hospital Puerta de Hierro, Madrid, Spain; Departamento de Dermatología, Hospital Clínic de Barcelona, Barcelona, Spain; Departamento de Dermatología, Hospital Infanta Leonor, Madrid, Spain; Departamento de Dermatología Hospital Universitario Puerta del Mar, Cádiz, Spain; Departamento de Dermatología, Hospital Universitari Vall d'Hebron, Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; Departamento de Dermatología, Hospital Clínico Universitario de Santiago, A Coruña, Spain; Departamento de Dermatología, Hospital Universitario Gregorio Marañon, Madrid, Spain; Departamento de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Departamento de Dermatología, Hospital Universitari Joan XXIII, Tarragona, Spain; Departamento de Dermatología, Hospital clínico San Carlos, Madrid, MD Anderson Cancer Center, Madrid, Spain; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain; Departamento de Dermatología, Hospital Universitario Severo Ochoa, Leganés, Spain; Departamento de Dermatología, Fundación Jiménez Diaz, Madrid, Spain; Departamento de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain; Departamento de Oncología Médica, Hospital Universitario La Princesa, Madrid, Spain; Departamento de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Actas Dermo-Sifiliograficas
|December 5, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Cell Population Analyses During Skin Carcinogenesis06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

12.9K
SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

25.0K

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183